Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 24, 2019--
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two investor conferences:
The presentations will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Prime’s product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Prime’s product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com or follow us on LinkedIn, Twitter and Facebook.
Source: Five Prime Therapeutics, Inc.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190524005408/en/
CONTACT: Media and Investor Contact
VP, Investor Relations & Corporate Communications
Five Prime Therapeutics, Inc.
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA COLORADO NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL
SOURCE: Five Prime Therapeutics, Inc.
Copyright Business Wire 2019.
PUB: 05/24/2019 04:01 PM/DISC: 05/24/2019 04:01 PM